Related Experiment Video
Updated: Jun 7, 2025

Author Spotlight: Investigating Bacteriophage-Induced Immune Responses in Gnotobiotic Mice
Published on: January 26, 2024
[Stent-associated urosepsis, personalized bacteriophage therapy]
S Perepanova T1, V Kazachenko A1, A Mesropyan S1
1N.A. Lopatkin Research Institute of Urology and Interventional Radiology branch of the National Medical Research Radiological Center, Moscow, Russia.
Bacteriophage therapy offers a promising alternative for treating infections caused by pan-resistant bacteria, especially in complex cases like stent-associated urosepsis. This clinical case highlights its successful application in a patient with severe complications from Klebsiella pneumoniae.
Area of Science:
- Infectious Diseases
- Microbiology
- Urology
Background:
- Antibiotic resistance necessitates novel therapeutic strategies beyond conventional antibiotics.
- Long-term ureteral stents can serve as foci for persistent infections, complicating patient management.
- Pan-resistant pathogens, such as Klebsiella pneumoniae, pose significant treatment challenges.
Observation:
- A 42-year-old patient with spinal cord injury and ureteral stricture developed severe stent-associated urosepsis after stent removal.
- The infection was caused by pan-resistant Klebsiella pneumoniae, leading to endotoxic shock and disseminated intravascular coagulation syndrome.
- Conventional antibiotic therapy was insufficient due to the pathogen's resistance profile.
Findings:
- Personalized local bacteriophage therapy was administered to the patient.
- The bacteriophage therapy effectively targeted the pan-resistant Klebsiella pneumoniae infection.
- Successful resolution of urosepsis, endotoxic shock, and wound sepsis was achieved.
Implications:
- Bacteriophage therapy presents a viable alternative for managing multidrug-resistant infections in clinical settings.
- This case underscores the importance of considering bacteriophages for complex, resistant infections, particularly those associated with medical devices.
- Further research into personalized bacteriophage cocktails could enhance treatment efficacy for challenging pathogens.
Related Concept Videos
Lytic Cycle of Bacteriophages
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Microorganisms in Medicine and Therapeutics
Gene Regulation in Microbial Communities: Quorum Sensing
Lysogenic Cycle of Bacteriophages
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...

